NO991078D0 - HIV peptider, antigener, vaksine sammensetninger, immunoassay kit og en metode for Õ pÕvise antistoffer indusert av HIV - Google Patents
HIV peptider, antigener, vaksine sammensetninger, immunoassay kit og en metode for Õ pÕvise antistoffer indusert av HIVInfo
- Publication number
- NO991078D0 NO991078D0 NO991078A NO991078A NO991078D0 NO 991078 D0 NO991078 D0 NO 991078D0 NO 991078 A NO991078 A NO 991078A NO 991078 A NO991078 A NO 991078A NO 991078 D0 NO991078 D0 NO 991078D0
- Authority
- NO
- Norway
- Prior art keywords
- hiv
- antigens
- peptides
- vaccine compositions
- antibodies induced
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000003018 immunoassay Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 108091005601 modified peptides Proteins 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229940021993 prophylactic vaccine Drugs 0.000 abstract 1
- 229940021747 therapeutic vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- AIDS & HIV (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19991078A NO311807B1 (no) | 1999-03-04 | 1999-03-04 | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
EP00911492A EP1159298B1 (en) | 1999-03-04 | 2000-03-02 | Hiv peptides, antigens and vaccine compositions |
ES00911492T ES2307496T4 (es) | 1999-03-04 | 2000-03-02 | Composiciones de vacuna, antígenos y péptidos de VIH |
BR0008741-6A BR0008741A (pt) | 1999-03-04 | 2000-03-02 | Peptìdeo de hiv, antìgenos, composições de vacina, kit de imunoensaio e método de detecção de anticorpos induzidos por hiv |
NZ525753A NZ525753A (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
NZ514619A NZ514619A (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
DK00911492T DK1159298T3 (da) | 1999-03-04 | 2000-03-02 | HIV-peptider, antigener og vaccinekompositioner |
PT00911492T PT1159298E (pt) | 1999-03-04 | 2000-03-02 | Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv |
JP2000602264A JP2002541069A (ja) | 1999-03-04 | 2000-03-02 | Hivペプチド、抗原、ワクチン組成物、免疫学的検定キット及びhivによって誘発された抗体を検出する方法 |
US09/674,674 US6706859B1 (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
AT00911492T ATE397014T1 (de) | 1999-03-04 | 2000-03-02 | Hiv-peptide, antigene und impfstoffzusammensetzungen |
CNB008057354A CN100387617C (zh) | 1999-03-04 | 2000-03-02 | Hiv肽,抗原,疫苗组合物,检测hiv所诱导的抗体的免疫测定试剂盒及方法 |
EA200100943A EA004802B9 (ru) | 1999-03-04 | 2000-03-02 | МОДИФИЦИРОВАННЫЕ ВИЧ-ПЕПТИДЫ НА ОСНОВЕ БЕЛКА gag p24, АНТИГЕНЫ, ВАКЦИННЫЕ КОМПОЗИЦИИ, НАБОР ДЛЯ ИММУНОАНАЛИЗА И СПОСОБ ОПРЕДЕЛЕНИЯ ВИЧ-ИНДУЦИРОВАННЫХ АНТИТЕЛ |
PCT/NO2000/000075 WO2000052040A1 (en) | 1999-03-04 | 2000-03-02 | Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
IDW00200102137A ID30497A (id) | 1999-03-04 | 2000-03-02 | Peptida hiv, antigen, komposisi vaksin, kit imunoasai dan metoda untuk mendeteksi antibodi yang diinduksi oleh hiv |
HU0200265A HU229282B1 (en) | 1999-03-04 | 2000-03-02 | Hiv vaccine compositions |
CNA2008100921326A CN101328210A (zh) | 1999-03-04 | 2000-03-02 | Hiv肽,抗原,疫苗组合物,检测hiv所诱导的抗体的免疫测定试剂盒及方法 |
CNA2008100921311A CN101328209A (zh) | 1999-03-04 | 2000-03-02 | Hiv肽,抗原,疫苗组合物,检测hiv所诱导的抗体的免疫测定试剂盒及方法 |
NZ525751A NZ525751A (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
CNA2008100921330A CN101328208A (zh) | 1999-03-04 | 2000-03-02 | Hiv肽,抗原,疫苗组合物,检测hiv所诱导的抗体的免疫测定试剂盒及方法 |
AU33358/00A AU771827B2 (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
SK1240-2001A SK287382B6 (sk) | 1999-03-04 | 2000-03-02 | Očkovacia kompozícia |
CA002363947A CA2363947C (en) | 1999-03-04 | 2000-03-02 | Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
NZ525752A NZ525752A (en) | 1999-03-04 | 2000-03-02 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
DE60039036T DE60039036D1 (de) | 1999-03-04 | 2000-03-02 | Hiv-peptide, antigene und impfstoffzusammensetzungen |
CZ20013195A CZ300505B6 (cs) | 1999-03-04 | 2000-03-02 | Vakcinacní prípravek |
ZA200107072A ZA200107072B (en) | 1999-03-04 | 2001-08-27 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV. |
HK02106292.0A HK1044778B (zh) | 1999-03-04 | 2002-08-27 | Hiv肽,抗原,疫苗組合物,檢測hiv所誘導的抗體的免疫測定試劑盒及方法 |
US10/659,324 US7311915B2 (en) | 1999-03-04 | 2003-09-11 | Method of producing an HIV-1 immune response |
US11/865,106 US7709003B2 (en) | 1999-03-04 | 2007-10-01 | Method of producing an HIV-1 immune response |
US11/865,109 US7709004B2 (en) | 1999-03-04 | 2007-10-01 | Method of producing an HIV-1 immune response |
CY20081100922T CY1108299T1 (el) | 1999-03-04 | 2008-08-28 | Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου |
JP2010275025A JP5313998B2 (ja) | 1999-03-04 | 2010-12-09 | Hivペプチド、抗原、ワクチン組成物、免疫学的検定キット及びhivによって誘発された抗体を検出する方法 |
JP2012239940A JP5695010B2 (ja) | 1999-03-04 | 2012-10-31 | Hivペプチド、抗原、ワクチン組成物、免疫学的検定キット及びhivによって誘発された抗体を検出する方法 |
JP2012240131A JP5695012B2 (ja) | 1999-03-04 | 2012-10-31 | Hivペプチド、抗原、ワクチン組成物、免疫学的検定キット及びhivによって誘発された抗体を検出する方法 |
JP2013249096A JP5814331B2 (ja) | 1999-03-04 | 2013-12-02 | Hivペプチド、抗原、ワクチン組成物、免疫学的検定キット及びhivによって誘発された抗体を検出する方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19991078A NO311807B1 (no) | 1999-03-04 | 1999-03-04 | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
Publications (3)
Publication Number | Publication Date |
---|---|
NO991078D0 true NO991078D0 (no) | 1999-03-04 |
NO991078L NO991078L (no) | 2000-09-05 |
NO311807B1 NO311807B1 (no) | 2002-01-28 |
Family
ID=19903050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19991078A NO311807B1 (no) | 1999-03-04 | 1999-03-04 | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
Country Status (23)
Country | Link |
---|---|
US (4) | US6706859B1 (no) |
EP (1) | EP1159298B1 (no) |
JP (5) | JP2002541069A (no) |
CN (4) | CN101328208A (no) |
AT (1) | ATE397014T1 (no) |
AU (1) | AU771827B2 (no) |
BR (1) | BR0008741A (no) |
CA (1) | CA2363947C (no) |
CY (1) | CY1108299T1 (no) |
CZ (1) | CZ300505B6 (no) |
DE (1) | DE60039036D1 (no) |
DK (1) | DK1159298T3 (no) |
EA (1) | EA004802B9 (no) |
ES (1) | ES2307496T4 (no) |
HK (1) | HK1044778B (no) |
HU (1) | HU229282B1 (no) |
ID (1) | ID30497A (no) |
NO (1) | NO311807B1 (no) |
NZ (4) | NZ514619A (no) |
PT (1) | PT1159298E (no) |
SK (1) | SK287382B6 (no) |
WO (1) | WO2000052040A1 (no) |
ZA (1) | ZA200107072B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001056355A2 (en) | 2000-02-04 | 2001-08-09 | Duke University | Human immunodeficiency virus vaccine |
NO314587B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
NO314588B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV |
SG170092A1 (en) | 2006-03-10 | 2011-04-29 | Peptcell Ltd | Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
CN102123724B (zh) | 2008-06-19 | 2018-05-01 | 变异生技公司 | 治疗流行性感冒的组合物和方法 |
CA2803282C (en) | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
AU2010270722B2 (en) | 2009-07-06 | 2015-06-04 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
EP2590674B1 (en) | 2010-07-06 | 2017-02-22 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
CN103282375B (zh) * | 2010-12-02 | 2017-01-11 | 比奥诺尔免疫有限公司 | 肽支架设计 |
EP2663327A4 (en) | 2011-01-13 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
CN104302323A (zh) | 2012-01-12 | 2015-01-21 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
AU2013213345A1 (en) | 2012-01-27 | 2014-08-28 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
MX2014014683A (es) * | 2012-06-06 | 2015-02-24 | Bionor Immuno As | Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion. |
US10335482B2 (en) | 2012-06-06 | 2019-07-02 | Bionor Immuno As | Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
WO2015007337A1 (en) | 2013-07-19 | 2015-01-22 | Bionor Immuno As | Method for the vaccination against hiv |
EP3033106A1 (en) * | 2013-08-14 | 2016-06-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Immunoadjuvant compositions and uses thereof |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
WO2015086738A2 (en) * | 2013-12-11 | 2015-06-18 | Bionor Immuno As | Hiv vaccine |
WO2015110665A1 (en) * | 2014-01-27 | 2015-07-30 | Bionor Immuno As | Dosage regimen for hiv vaccine |
AU2015208033B2 (en) | 2014-01-27 | 2019-02-07 | Bionor Immuno As | Method for the vaccination against HIV |
WO2015110659A1 (en) * | 2014-01-27 | 2015-07-30 | Bionor Immuno As | Methods of immunization with a vaccine inducing a humoral immune response and with a vaccine inducing a cellular immune response |
MX2016012965A (es) | 2014-04-03 | 2017-07-06 | Amgen Inc | Metodo para preparar amg 416. |
EP3166633A1 (en) | 2014-07-11 | 2017-05-17 | Bionor Immuno AS | Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids) |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
WO2016177833A1 (en) | 2015-05-04 | 2016-11-10 | Bionor Immuno As | Dosage regimen for hiv vaccine |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO870027L (no) | 1986-01-06 | 1987-07-07 | Hoffmann La Roche | Ekspresjon av htlv-iii gag-gen. |
US4925784A (en) | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
GB8629116D0 (en) | 1986-12-05 | 1987-01-14 | Hoffmann La Roche | Env/gag polypeptides |
EP0307149B1 (en) | 1987-09-04 | 1993-01-07 | International Murex Technologies Corporation | Solid phase immunoassay for an antibody and biological constructions for use therein |
US4888290A (en) * | 1987-11-06 | 1989-12-19 | Coulter Corporation | Monoclonal antibody specific to HIV antigens |
EP0356007A3 (en) * | 1988-07-22 | 1991-07-03 | Medical Research Council | Antigenic determinants |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
SE468168B (sv) | 1990-02-20 | 1992-11-16 | Replico Medical Ab | Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov |
US5288514A (en) * | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
FR2703252B1 (fr) * | 1993-03-31 | 1996-09-06 | Fernand Narbey Torossian | Complexe immunomodulateur anti SIDA. |
WO1994028871A1 (en) * | 1993-06-07 | 1994-12-22 | Endocon, Inc. | Implant stimulated cellular immunity |
AU685521B2 (en) * | 1993-10-19 | 1998-01-22 | Ajinomoto Co., Inc. | Peptide capable of inducing immune response against HIV and aids preventive or remedy containing the peptide |
FR2731013B1 (fr) * | 1995-02-27 | 1997-05-16 | Inst Nat Sante Rech Med | Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications |
ATE228248T1 (de) | 1997-03-10 | 2002-12-15 | Roche Diagnostics Gmbh | Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern |
-
1999
- 1999-03-04 NO NO19991078A patent/NO311807B1/no not_active IP Right Cessation
-
2000
- 2000-03-02 CN CNA2008100921330A patent/CN101328208A/zh active Pending
- 2000-03-02 HU HU0200265A patent/HU229282B1/hu not_active IP Right Cessation
- 2000-03-02 DE DE60039036T patent/DE60039036D1/de not_active Expired - Lifetime
- 2000-03-02 BR BR0008741-6A patent/BR0008741A/pt not_active IP Right Cessation
- 2000-03-02 US US09/674,674 patent/US6706859B1/en not_active Expired - Lifetime
- 2000-03-02 EP EP00911492A patent/EP1159298B1/en not_active Expired - Lifetime
- 2000-03-02 CZ CZ20013195A patent/CZ300505B6/cs not_active IP Right Cessation
- 2000-03-02 NZ NZ514619A patent/NZ514619A/en not_active IP Right Cessation
- 2000-03-02 NZ NZ525752A patent/NZ525752A/en not_active IP Right Cessation
- 2000-03-02 CN CNA2008100921311A patent/CN101328209A/zh active Pending
- 2000-03-02 ID IDW00200102137A patent/ID30497A/id unknown
- 2000-03-02 AU AU33358/00A patent/AU771827B2/en not_active Ceased
- 2000-03-02 AT AT00911492T patent/ATE397014T1/de active
- 2000-03-02 CN CNA2008100921326A patent/CN101328210A/zh active Pending
- 2000-03-02 NZ NZ525751A patent/NZ525751A/en not_active IP Right Cessation
- 2000-03-02 NZ NZ525753A patent/NZ525753A/en not_active IP Right Cessation
- 2000-03-02 SK SK1240-2001A patent/SK287382B6/sk not_active IP Right Cessation
- 2000-03-02 CA CA002363947A patent/CA2363947C/en not_active Expired - Fee Related
- 2000-03-02 PT PT00911492T patent/PT1159298E/pt unknown
- 2000-03-02 ES ES00911492T patent/ES2307496T4/es not_active Expired - Lifetime
- 2000-03-02 WO PCT/NO2000/000075 patent/WO2000052040A1/en active IP Right Grant
- 2000-03-02 JP JP2000602264A patent/JP2002541069A/ja active Pending
- 2000-03-02 CN CNB008057354A patent/CN100387617C/zh not_active Expired - Fee Related
- 2000-03-02 EA EA200100943A patent/EA004802B9/ru not_active IP Right Cessation
- 2000-03-02 DK DK00911492T patent/DK1159298T3/da active
-
2001
- 2001-08-27 ZA ZA200107072A patent/ZA200107072B/xx unknown
-
2002
- 2002-08-27 HK HK02106292.0A patent/HK1044778B/zh not_active IP Right Cessation
-
2003
- 2003-09-11 US US10/659,324 patent/US7311915B2/en not_active Expired - Fee Related
-
2007
- 2007-10-01 US US11/865,106 patent/US7709003B2/en not_active Expired - Fee Related
- 2007-10-01 US US11/865,109 patent/US7709004B2/en not_active Expired - Fee Related
-
2008
- 2008-08-28 CY CY20081100922T patent/CY1108299T1/el unknown
-
2010
- 2010-12-09 JP JP2010275025A patent/JP5313998B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-31 JP JP2012239940A patent/JP5695010B2/ja not_active Expired - Fee Related
- 2012-10-31 JP JP2012240131A patent/JP5695012B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-02 JP JP2013249096A patent/JP5814331B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991078D0 (no) | HIV peptider, antigener, vaksine sammensetninger, immunoassay kit og en metode for Õ pÕvise antistoffer indusert av HIV | |
MY136081A (en) | Modified hiv - 1gag p17 peptide and immunogenic composition | |
Henderson et al. | Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III | |
CA1341620C (en) | Envelope antigens of hiv-1 | |
BR0210598A (pt) | Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie | |
MXPA02007413A (es) | Vacuna para la inmunizacion profilactica o terapeutica contra el vih. | |
WO2002020555A3 (en) | Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components | |
Shafferman et al. | Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection | |
Kennedy et al. | Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. | |
EP1016671A3 (en) | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) | |
Lizeng et al. | Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection | |
DeVICO et al. | Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase | |
GR3033885T3 (en) | Synthetic antigens for the detection of aids-related disease caused by LAV-2. | |
Pyle et al. | Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF | |
Partidos et al. | The binding affinity of double‐stranded RNA motifs to HIV‐1 Tat protein affects transactivation and the neutralizing capacity of anti‐Tat antibodies elicited after intranasal immunization | |
WIELAND et al. | Antigenic domains of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies | |
Chattopadhya et al. | Profile of antigen-specific antibody response detectable by Western blot in relation to diagnostic criteria for human immunodeficiency virus type-1 (HIV-1) infection | |
Chen et al. | A common immunological epitope existing between HIV-1 gp41 and human interferon-α and-β | |
FR2874017B1 (fr) | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih | |
Gnann Jr et al. | Designing Peptides to Immunologically Distinguish Specific Human Immunodeficiency Virus Isolates | |
Human | JOHN W. GNANN, JR, AND MICHAEL BA OLDSTONE | |
TH65071A (th) | เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |